Certolizumab pegol antibody drug (pegylated Fab' fragment). Targets TNF-a; indications for use include Crohn's disease, rheumatoid arthritis and ankyl

---

Certolizumab pegol antibody drug (pegylated Fab' fragment). Targets TNF-a; indications for use include Crohn's disease, rheumatoid arthritis and ankylosing spondylitis. Generic name and stylized antibody.

---

Size: 9000px × 3673px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: alpha, ankylosing, antibody, arthritis, autoimmune, biological, biosimilar, biotech, biotechnology, certolizumab, crohn, disease, drug, glycol, immunoglobulin, immunology, infusion, injection, inn, mab, monoclonal, necrosis, nomenclature, peg, pegol, pegylated, peptide, polyethylene, protein, psoriatic, rheumatoid, spondylitis, tnf-, tumor